QualityStocksNewsBreaks Archives - Page 326 of 1457

WednesdayApr 05, 2023 11:31 am

QualityStocksNewsBreaks – Arizona Metals Corp. (TSX: AMC) (OTCQX: AZMCF) Releases Results of Kay Mine Project Exploration Drilling

Arizona Metals Corp. (TSX: AMC) (OTCQX: AZMCF), based in Arizona and focused on copper and gold exploration, is reporting on step-out exploration drilling at its Kay Mine Deposit. According to the announcement, the exploration drilling has intersected a potential new zone of copper-gold-zinc VMS mineralization; the new zone is located 600 meters north along the strike of the Central Target EM anomaly. The company reported that clasts of massive sulphide mineralization have been observed, which can be indicative of primary massive sulphide mineralization. Based on the indications, follow-up drilling is being planned to test for extensions of the mineralization encountered…

TuesdayApr 04, 2023 12:39 pm

QualityStocksNewsBreaks — Mullen Automotive Inc. (NASDAQ: MULN) Announces Completion of Pilot Program at LAX; Accelerates Integration of New Battery Tech

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, has successfully concluded a 60-day commercial EV pilot program with Menzies Aviation and Loop Global Inc. at the Los Angeles International Airport (“LAX”). Menzies currently operates in 250-plus airports in 58 countries to provide ground, air cargo and fuel services to commercial airports and airlines. During the pilot program, Menzies used two class 1 EV vans at the airport to transport both equipment and personnel, powering the vehicles with Loop-installed level 2 chargers. The vans drove more than 1,500 miles during the program, with a reported 100% uptime and zero maintenance issues.…

TuesdayApr 04, 2023 12:05 pm

QualityStocksNewsBreaks – Eloro Resources Ltd. (TSX: ELO) (OTCQX: ELRRF) (FSE: P2QM) Provides Update on Ongoing Preliminary Testwork for Iska Iska Project

Eloro Resources (TSX: ELO) (OTCQX: ELRRF) (FSE: P2QM) today provided an update on its ongoing preliminary metallurgical testwork program for the Iska Iska silver-tin polymetallic project in the Potosi Department, southern Bolivia. The ongoing work is being carried out by Blue Coast Research Ltd. (“BCR”) based in Parksville, British Columbia, and Mineral Concentration Laboratory of the National Faculty of Engineering from the Technical University of Oruro (“UTO”), Bolivia. “The Iska Iska silver-tin polymetallic deposit is a remarkably extensive system with multiple potential ore types, which require more metallurgical work than originally anticipated, especially for tin, as outlined in this press…

TuesdayApr 04, 2023 11:50 am

QualityStocksNewsBreaks – Delic Holdings Corp. (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0) Inks LOI for Acquisition of Ketamine Wellness Centers

Delic Holdings (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0), a leader in new medicines and treatments for a modern world, has signed a letter of intent with Peter/PetraMD, the largest online provider of hormone therapy in the United States for the acquisition of Ketamine Wellness Centers. According to the announcement, the acquisition provides an incredible on-ramp into the ketamine space for Peter/PetraMD, which has more than 20 years of experience and nearly 100,000 patients across the United States. Ketamine Wellness Centers is the largest ketamine infusion therapy provider in the country. According to the announcement, Peter/PetraMD plans to maintain continuity of care…

MondayApr 03, 2023 3:16 pm

QualityStocksNewsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) DehydraTECH(TM) Provides Foundation for Improving Effectiveness of Lipophilic Drugs, APIs

Lexaria Bioscience Corp. (NASDAQ: LEXX), a global innovator in drug delivery platforms, is positioned for opportunity with its patented DehydraTECH(TM) technology and its wide-reaching potential. “Lexaria’s DehydraTECH is designed to formulate and deliver lipophilic (fat-soluble) drugs and active pharmaceutical ingredients (‘APIs’). DehydraTECH increases the effectiveness of and improves the way APIs enter the bloodstream. The benefits of consuming a DehydraTECH-enabled drug or product include: speed up in delivery time; increased bioavailability; increased brain absorption; improved drug potency; and reduction in drug administration costs. Animal studies of DehydraTECH have demonstrated the ability to elevate the quantity of the drug delivered across…

MondayApr 03, 2023 2:55 pm

QualityStocksNewsBreaks – BiondVax Pharmaceuticals Ltd.’s (NASDAQ: BVXV) Lead NanoAb Candidate Holds Significant Advantages to Existing Therapies

BiondVax (NASDAQ: BVXV), which focuses on developing, manufacturing and commercializing innovative immunotherapeutic products primarily for the treatment of infectious and autoimmune diseases, has shown, through an ongoing in vivo preclinical proof-of-concept study, that its lead NanoAb candidate for the treatment of COVID-19 exhibits clear competitive advantages over existing monoclonal antibodies (“mAbs”) and oral therapies. “According to statistically significant results released early January, BiondVax established that its inhaled therapy virtually eliminated the SARS-CoV-2 virus and prevented illness when administered prophylactically… The second set of results, announced January 23, evidenced that when the NanoAb was administered by inhalation three hours before infection,…

MondayApr 03, 2023 2:32 pm

QualityStocksNewsBreaks – McEwen Mining Inc.’s (NYSE: MUX) (TSX: MUX) Subsidiary Collaborating in Vision to ‘Build a Mine for the Future’

McEwen Mining’s (NYSE: MUX) (TSX: MUX) 51.9%-owned subsidiary, McEwen Copper, recently closed an ARS 30 billion investment by FCA Argentina S.A., a subsidiary of Stellantis N.V. (NYSE: STLA). Proceeds from the investment are expected to be directed toward advancing the development of McEwen Copper’s 100%-owned Los Azules project in San Juan, Argentina. “We are delighted to have Stellantis as a partner in the future development of our Los Azules copper project,” McEwen Copper CEO Rob McEwen is quoted as saying of the investment. “Together, we share a vision to build a mine for the future based on regenerative principles that…

MondayApr 03, 2023 2:19 pm

QualityStocksNewsBreaks – Knightscope, Inc. (NASDAQ: KSCP) Announces New PO from California College, New Service Deal with Denver Airport

Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots and blue light emergency communication systems, has received an order from Mt. San Antonio College. The order is for 11 K1 Blue Light Towers and 7 K1 Emergency Phones along with a one-year full-service maintenance plan. In addition, the company inked a deal with the Denver International Airport Annual to provide a monitoring and wireless service plan for 40 K1 Call Boxes that are installed along the main road leading to and from the airport as well as at other locations around the airport property. Located in California, Mt. San…

MondayApr 03, 2023 12:58 pm

QualityStocksNewsBreaks – Jupiter Wellness Inc. (NASDAQ: JUPW) Announces Q4 and FY 2022 Financial Results

Jupiter Wellness (NASDAQ: JUPW), a company focused on hair, skin and sexual wellness, today announced results for the fourth quarter and year ended Dec. 31, 2022. Among the highlights, the company reported $6,196,743 in revenues compared to $2,876,273 for the year ended Dec. 31, 2021. “I am extremely pleased with how far we have come in such a short time,” said Brian John, CEO of Jupiter Wellness. “In 2022, we shifted out of the CBD space and acquired and established new unique IP and products with little competition. We look forward to focusing on selling our brands and becoming profitable…

MondayApr 03, 2023 12:40 pm

QualityStocksNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Announces FY 2022 Results, Corporate Update

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, today released its financial results for the full year ended Dec. 31, 2022. The company also provided a clinical update of its anti-cancer drug candidate currently in development for the treatment of primary and metastatic brain and CNS cancer. “Over the course of 2022, we made significant advancements in our ongoing clinical trial for Berubicin. We have expanded our clinical trial sites across Europe and continued with an encouraging and increasingly rapid pace of…

Site Search

Company Search

Category: QualityStocksNewsBreaks